Document:

Exhibit 4.2

 

Option Number XX-XXXX-X

 

180 LIFE SCIENCES CORP.

 

2020 OMNIBUS INCENTIVE PLAN

 

STOCK OPTION AGREEMENT

 

Unless otherwise defined herein,
the terms in the Stock Option Agreement (the “Option Agreement”) have the same meanings as defined in the 180
Life Sciences Corp. 2020 Omnibus Incentive Plan (as amended from time to time)(the “Plan”).

 

I.
NOTICE OF STOCK OPTION GRANT

 

Optionee: <<Optionee>>

 

Address: ___________________________________

 

You have been granted an Option
to purchase Company Common Stock of the Company (the “Option”), subject to the terms and conditions of the Plan
and this Option Agreement, as follows:

 

Grant Date: <<Grant
Date>>

 

Vesting Commencement Date: <<Grant
Date>>

 

Exercise Price per Share:
$<<Exercise Price>>

 

Total Number of Shares
Granted: <<Total Shares>>

 

Total Exercise Price: $<<Total
Exercise Price>>

 

Type of Option: ________________________

 

Expiration Date: ________________________

 

Vesting Schedule: The
Options vest at the rate of ________________________, subject to the Optionee’s continued service to the Company.
Notwithstanding the above, all of the unvested Options shall vest immediately upon Optionee’s death or Disability, termination of
employment without cause or a termination of Optionee for good reason (each as defined and described in Optionee’s employment agreement),
a Change in Control of the Company.

 

     

     

    

 

To the extent vested, this
Option will be exercisable for three (3) months following the termination of service of Optionee, unless termination is due to Optionee’s
death or Disability, in which case this Option will be exercisable for twelve (12) months following the termination of service
of Optionee. In the event of termination due to Optionee’s death, the Company shall use commercially reasonable efforts to notify
Optionee’s estate of the exercisability of the Option following Optionee’s death. Notwithstanding the foregoing sentence,
in no event may this Option be exercised following the termination of service of Optionee as determined by the Company’s Board to
be for Cause or after the Expiration Date as provided above and this Option may be subject to earlier termination as provided in the Plan.

 

“Cause”
has the meaning ascribed to such term or words of similar import in Optionee’s written employment or service contract with the Company
or its parent or any subsidiary and, in the absence of such agreement or definition, means Optionee’s (i) conviction of, or
plea of nolo contendere to, a felony or any other crime involving moral turpitude; (ii) fraud on or misappropriation of any funds
or property of the Company or its subsidiaries, or any affiliate, customer or vendor; (iii) personal dishonesty, incompetence, willful
misconduct, willful violation of any law, rule or regulation (other than minor traffic violations or similar offenses), or breach of fiduciary
duty which involves personal profit; (iv) willful misconduct in connection with Optionee’s duties or willful failure to perform
Optionee’s responsibilities in the best interests of the Company or its subsidiaries; (v) illegal use or distribution of drugs;
(vi) violation of any material rule, regulation, procedure or policy of the Company or its subsidiaries, the violation of which could
have a material detriment to the Company; or (vii) material breach of any provision of any employment, non-disclosure, non-competition,
non-solicitation or other similar agreement executed by Optionee for the benefit of the Company or its subsidiaries, all as reasonably
determined by the Company’s Board of Directors, which determination will be conclusive.

 

Legends.

 

(a) All
certificates representing the Shares issued upon exercise of this Option shall, prior to such date as the Plan and Company Common Stock
hereunder are covered by a valid Form S-8 or similar U.S. federal registration statement, where applicable, have endorsed thereon the
following legend:

 

THE SECURITIES
REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES
LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS
OF U.S. FEDERAL, STATE AND FOREIGN SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT
REGISTRATION AND QUALIFICATION UNDER U.S. FEDERAL, STATE AND FOREIGN SECURITIES LAWS IS NOT REQUIRED.

 

    2020 Stock Option Agreement
Option Number XX-XXXX-X
Page 2 of 10

     

    

 

(b) If
the Option is an incentive stock option (ISO), then the following legend will be included:

 

THE SHARES
REPRESENTED BY THIS CERTIFICATE WERE ISSUED UPON EXERCISE OF AN INCENTIVE STOCK OPTION, AND THE COMPANY MUST BE NOTIFIED IF THE SHARES
SHALL BE TRANSFERRED BEFORE THE LATER OF THE TWO (2) YEAR ANNIVERSARY OF THE DATE OF GRANT OF THE OPTION OR THE ONE (1) YEAR ANNIVERSARY
OF THE DATE ON WHICH THE OPTION WAS EXERCISED. THE REGISTERED HOLDER MAY RECOGNIZE ORDINARY INCOME IF THE SHARES ARE TRANSFERRED BEFORE
SUCH DATE.

 

II. AGREEMENT

 

1. Grant of Option.
The Administrator grants to the Optionee named in the Notice of Stock Option Grant in Part I of this Option Agreement,
an Option to purchase the number of Shares set forth in the Notice of Stock Option Grant, at the exercise price per Share set forth in
the Notice of Stock Option Grant (the “Exercise Price”), and subject to the terms and conditions of the Plan,
which is incorporated herein by reference. In the event of a conflict between the terms and conditions of the Plan and this Option Agreement,
the terms and conditions of the Plan prevail.

 

If designated in the Notice
of Stock Option Grant as an Incentive Stock Option, this Option is intended to qualify as an Incentive Stock Option as defined in Code
section 422. Nevertheless, to the extent that it exceeds the $100,000 rule of Code section 422(d), this Option will be treated
as a Nonstatutory/Non-Qualified Stock Option.

 

2. Exercise of Option.

 

(a) Right to Exercise.
This Option is exercisable during its term in accordance with the Vesting Schedule set out in the Notice of Stock Option Grant and with
the applicable provisions of the Plan and this Option Agreement.

 

(b) Method of Exercise.
This Option is exercisable by (i) delivery of an exercise notice in the form attached as Exhibit A (the “Exercise
Notice”) or in a manner and pursuant to procedures as the Administrator may determine, which will state the election to
exercise the Option, the number of Shares with respect to which the Option is being exercised, and other representations and agreements
as may be required by the Company and (ii) paying the Company in full the aggregate Exercise Price as to all Shares being acquired, together
with any applicable tax withholding.

 

This Option will be deemed to
be exercised upon receipt by the Company of a fully executed Exercise Notice accompanied by the aggregate Exercise Price, together with
any applicable tax withholding.

 

    2020 Stock Option Agreement
Option Number XX-XXXX-X
Page 3 of 10

     

    

 

No Shares will be issued pursuant
to the exercise of an Option unless the issuance and exercise of Shares complies with applicable state and federal laws (“Applicable
Laws”). Assuming compliance, for income tax purposes the Shares will be considered transferred to the Optionee on the date
on which the Option is exercised with respect to the Shares.

 

3. Method of Payment.
The aggregate Exercise Price may be paid by any of the following, or a combination thereof, at the election of the Optionee:

 

(a) cash;

 

(b) check;

 

(c) to the extent not prohibited
by Section 402 of the Sarbanes-Oxley Act of 2002, a promissory note;

 

(d) other shares of Company
Common Stock, provided Shares have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as
to which said Option will be exercised;

 

(e) by asking the Company to
withhold Shares from the total Shares to be delivered upon exercise equal to the number of Shares having a value equal to the aggregate
Exercise Price of the Shares being acquired;

 

(f) any combination of the foregoing
methods of payment; or

 

(g) such other consideration
and method of payment for the issuance of Shares to the extent permitted by Applicable Laws.

 

4. Restrictions on
Exercise. This Option may not be exercised if the issuance of such Shares upon such exercise or the method of payment of consideration
for such shares would constitute a violation of any Applicable Laws. The Company will be relieved of any liability with respect to any
delayed issuance of shares or its failure to issue shares if such delay or failure is necessary to comply with Applicable Laws.

 

5. Non-Transferability
of Option. This Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may
be exercised during the lifetime of Optionee only by Optionee. The terms of the Plan and this Option Agreement are binding upon the executors,
administrators, heirs, successors and assigns of the Optionee.

 

6. Term of Option.
This Option may be exercised only within the term set out in the Notice of Stock Option Grant, and may be exercised during the term only
in accordance with the Plan and the terms of this Option.

 

    2020 Stock Option Agreement
Option Number XX-XXXX-X
Page 4 of 10

     

    

 

7. Tax Obligations.

 

(a) Withholding Taxes.
Optionee agrees to arrange for the satisfaction of all Federal, state, local and foreign income and employment tax withholding requirements
applicable to the Option exercise. Optionee acknowledges and agrees that the Company may refuse to honor the exercise and refuse to deliver
the Shares if withholding amounts are not delivered at the time of exercise.

 

(b) Notice of Disqualifying
Disposition of ISO Shares. If the Option granted to Optionee is an Incentive Stock Option (“ISO”), and if
Optionee sells or otherwise disposes of any of the Shares acquired pursuant to the ISO on or before the later of (i) the date two
(2) years after the Grant Date, or (ii) the date one (1) year after the date of exercise, the Optionee must immediately notify the
Company of the disposition in writing. Optionee agrees that Optionee may be subject to income tax withholding by the Company on the compensation
income recognized by the Optionee.

 

(c) Code Section 409A.
Under Code section 409A, an Option that was granted with a per Share exercise price that is determined by the Internal Revenue Service
(the “IRS”) to be less than the Fair Market Value of a Share on the Grant Date (a “discount option”)
may be considered deferred compensation. An Option that is a discount option may result in (i) income recognition by the Optionee prior
to the exercise of the Option, (ii) an additional tax, and (iii) potential penalty and interest charges. Optionee acknowledges that the
Company cannot and has not guaranteed that the IRS will agree that the per Share Exercise Price of this Option equals or exceeds Fair
Market Value of a Share on the Grant Date in a later examination. Optionee agrees that if the IRS determines that the Option was granted
with a per Share exercise price that was less than the Fair Market Value of a Share on the Grant Date, Optionee will be solely responsible
for any and all resulting tax consequences.

 

8. No Guarantee of Continued
Service. OPTIONEE ACKNOWLEDGES AND AGREES THAT THE VESTING OF SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING
AS AN EMPLOYEE AND/OR DIRECTOR (AS APPLICABLE) AT THE WILL OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING OPTIONEE)
AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS OPTION OR ACQUIRING SHARES HEREUNDER. OPTIONEE FURTHER ACKNOWLEDGES AND AGREES
THAT THIS OPTION AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS
OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS AN EMPLOYEE AND/OR DIRECTOR (AS APPLICABLE) FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT
ALL, AND WILL NOT INTERFERE IN ANY WAY WITH OPTIONEE’S RIGHT OR THE RIGHT OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING
OR RETAINING OPTIONEE) TO TERMINATE OPTIONEE’S RELATIONSHIP AS AN EMPLOYEE OR DIRECTOR AT ANY TIME, WITH OR WITHOUT CAUSE.

 

    2020 Stock Option Agreement
Option Number XX-XXXX-X
Page 5 of 10

     

    

 

9. Notices. All notices
or other communications which are required or permitted hereunder will be in writing and sufficient if (i) personally delivered or sent
by telecopy, (ii) sent by nationally-recognized overnight courier or (iii) sent by registered or certified mail, postage prepaid, return
receipt requested, addressed as follows:

 

(a) if to the Optionee, to the
address (or telecopy number) set forth on the Notice of Stock Option Grant; and

 

(b) if to the Company, to its
principal executive office as specified in any report filed by the Company with the Securities and Exchange Commission or to such address
as the Company may have specified to the Optionee in writing, Attention: Corporate Secretary;

 

or to any other address as the
party to whom notice is to be given may have furnished to the other party in writing in accordance herewith. Any communication will be
deemed to have been given (i) when delivered, if personally delivered, or when telecopied, if telecopied, (ii) on the first Business Day
(as hereinafter defined) after dispatch, if sent by nationally-recognized overnight courier and (iii) on the fourth Business Day following
the date on which the piece of mail containing the communication is posted, if sent by mail. As used herein, “Business Day”
means a day that is not a Saturday, Sunday or a day on which banking institutions in the city to which the notice or communication is
to be sent are not required to be open.

 

10. Specific Performance.
Optionee expressly agrees that the Company will be irreparably damaged if the provisions of this Option Agreement and the Plan are not
specifically enforced. Upon a breach or threatened breach of the terms, covenants and/or conditions of this Option Agreement or the Plan
by the Optionee, the Company will, in addition to all other remedies, be entitled to a temporary or permanent injunction, without showing
any actual damage, and/or decree for specific performance, in accordance with the provisions hereof and thereof. The Administrator has
the power to determine what constitutes a breach or threatened breach of this Option Agreement or the Plan. The Administrator’s
determinations will be final and conclusive and binding upon the Optionee.

 

11. No Waiver. No waiver
of any breach or condition of this Option Agreement will be deemed to be a waiver of any other or subsequent breach or condition, whether
of like or different nature.

 

12. Optionee Undertaking.
The Optionee agrees to take whatever additional actions and execute whatever additional documents the Company may in its reasonable judgment
deem necessary or advisable in order to carry out or effect one or more of the obligations or restrictions imposed on the Optionee pursuant
to the express provisions of this Option Agreement.

 

13. Modification of Rights.
The rights of the Optionee are subject to modification and termination in certain events as provided in this Option Agreement and the
Plan.

 

14. Governing Law.
This Agreement is governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to its conflict
or choice of law principles that might otherwise refer construction or interpretation of this Agreement to the substantive law of another
jurisdiction.

 

15. Counterparts; Facsimile
Execution. This Option Agreement may be executed in one or more counterparts, each of which will be deemed to be an original, but
all of which together constitute one and the same instrument. Facsimile execution and delivery of this Option Agreement is legal, valid
and binding execution and delivery for all purposes.

 

16. Entire Agreement.
The Plan, this Option Agreement, and upon execution, the Exercise Notice, constitute the entire agreement of the parties with respect
to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Optionee with respect
to the subject matter hereof, and may not be modified adversely to the Optionee’s interest except by means of a writing signed by
the Company and Optionee.

 

17. Severability. In
the event one or more of the provisions of this Option Agreement should, for any reason, be held to be invalid, illegal or unenforceable
in any respect, such invalidity, illegality or unenforceability will not affect any other provisions of this Option Agreement, and this
Option Agreement will be construed as if such invalid, illegal or unenforceable provision had never been contained herein.

 

18. WAIVER OF JURY TRIAL.
THE OPTIONEE EXPRESSLY, IRREVOCABLY AND UNCONDITIONALLY WAIVES TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS OPTION
AGREEMENT AND FOR ANY COUNTERCLAIM THEREIN.

 

[Remainder of page left intentionally blank.]

 

    2020 Stock Option Agreement
Option Number XX-XXXX-X
Page 6 of 10

     

    

 

Optionee acknowledges receipt
of a copy of the Plan and represents that he or she is familiar with the terms and provisions thereof, and accepts this Option subject
to all of the terms and provisions thereof. Optionee has reviewed the Plan and this Option in their entirety, has had an opportunity to
obtain the advice of counsel prior to executing this Option and fully understands all provisions of the Option. Optionee agrees to accept
as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan or this
Option. Optionee further agrees to notify the Company upon any change in the residence address indicated below.

 

	OPTIONEE 	180 LIFE SCIENCES CORP.
	 	 
	Signature	 	

     
	By:	 	 

	 	 
	Print Name:	<<Optionee>>	 	Print Name:	 	 

	 	 
	Address:	 	 
	Address:	 	 

	 	 	 	 	 	 
	 	 	 	 	 
	Date Signed: 	 	

     
	Date Signed:	 	

     

 

    2020 Stock Option Agreement
Option Number XX-XXXX-X
Page 7 of 10

     

    

 

EXHIBIT A

 

2020 OMNIBUS INCENTIVE PLAN

 

EXERCISE NOTICE

 

180 Life Sciences Corp.

3000 El Camino Real, Bldg. 4, Suite 200

Palo Alto, California 94306

 

Attention: 180 Life Sciences Corp., Corporate
Secretary

 

1.  Exercise
of Option. Effective as of today, _____________, _____,

___________ (“Optionee”) elects to exercise Optionee’s option to purchase ___________ shares of the Company
Common Stock (the “Shares”) of 180 Life Sciences Corp. (the “Company”) under and pursuant
to the 180 Life Sciences Corp. 2020 Omnibus Incentive Plan (as amended from time to time, the “Plan”) and the
Stock Option Agreement effective <<Grant Date>> (the “Option Agreement”).

 

2.  Delivery
of Payment. Optionee herewith delivers to the Company the full purchase price of the Shares, as set forth in the Option Agreement,
and any and all withholding taxes due in connection with the exercise of the Option.

 

3.  Representations
of Optionee. Optionee acknowledges that Optionee has received, read and understood the Plan and the Option Agreement and agrees to
abide by and be bound by their terms and conditions.

 

4.  Rights
as Stockholder. Until the issuance of the Shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized
transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder exists with respect to the
Optioned Stock, notwithstanding the exercise of the Option. Subject to the requirements of Section 6 below, the Shares
will be issued to the Optionee as soon as practicable after the Option is exercised in accordance with the Option Agreement. No adjustment
will be made for a dividend or other right for which the record date is prior to the date of issuance except as provided in the Plan.

 

5.  Tax
Consultation. Optionee understands that Optionee may suffer adverse tax consequences as a result of Optionee’s purchase or disposition
of the Shares. Optionee represents that Optionee has consulted with any tax consultants Optionee deems advisable in connection with the
purchase or disposition of the Shares and that Optionee is not relying on the Company for any tax advice.

 

6.  Refusal
to Transfer. The Company will not (i) transfer on its books any Shares that have been sold or otherwise transferred in violation of
any of the provisions of this Exercise Notice, or (ii) be required to treat as owner of such Shares or to accord the right to vote or
pay dividends to any purchaser or other transferee to whom such Shares have been so transferred.

 

    2020 Stock Option Agreement
Option Number XX-XXXX-X
Page 8 of 10

     

    

 

7.  Successors
and Assigns. The Company may assign any of its rights under this Exercise Notice to single or multiple assignees, and this Exercise
Notice inures to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this
Exercise Notice is binding upon Optionee and his or her heirs, executors, administrators, successors and assigns.

 

8.  Interpretation.
Any dispute regarding the interpretation of this Exercise Notice will be submitted by Optionee or by the Company forthwith to the Administrator
for review at its next regular meeting. The resolution of disputes by the Administrator will be final and binding on all parties.

 

9.  Governing
Law; Severability. This Exercise Notice is governed by, and construed in accordance with, the laws of the State of Delaware, without
giving effect to its conflict or choice of law principles that might otherwise refer construction or interpretation of this Exercise to
the substantive law of another jurisdiction. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction
to be illegal, unenforceable or void, this Exercise Notice will continue in full force and effect.

 

10.
Optionee Representations.

 

(a) With
respect to a transaction occurring prior to such date as the Plan and Company Common Stock thereunder are covered by a valid Form S-8
or similar U.S. federal registration statement, Optionee agrees that in no event shall Optionee make a disposition of any of the Company
Common Stock, unless and until: (i) Optionee shall have notified the Company of the proposed disposition and shall have furnished the
Company with a statement of the circumstances surrounding the proposed disposition; and (ii) Optionee shall have furnished the Company
with an opinion of counsel satisfactory to the Company to the effect that (A) such disposition will not require registration or qualification
of such Company Common Stock under applicable U.S. federal, state or foreign securities laws or (B) appropriate action necessary for compliance
with the U.S. federal, state or foreign securities laws has been taken; or (iii) the Company shall have waived, expressly and in writing,
its rights under clauses (i) and (ii) of this Subsection.

 

(b) Optionee
understands that if a registration statement covering the Company Common Stock under the Securities Act is not in effect when Optionee
desires to sell the Company Common Stock, Optionee may be required to hold the Company Common Stock for an indeterminate period. Optionee
also acknowledges that Optionee understands that any sale of the Company Common Stock which might be made by Optionee in reliance upon
Rule 144 under the Securities Act may be made only in limited amounts in accordance with the terms and conditions of that Rule.

 

11. Other
Documents. Optionee hereby acknowledges receipt or the right to receive a document providing the information required by Rule 428(b)(1)
promulgated under the Securities Act of 1933, as amended, including, but not limited to, the information required by Part I of Form S-8,
if applicable.

 

12.  Notices.
Any notice required or permitted hereunder will be provided in writing and deemed effective if provided in the manner specified in the
Option Agreement.

 

13.  Further
Instruments. The parties agree to execute any further instruments and to take any further action as may be reasonably necessary to
carry out the purposes and intent of the Option Agreement and this Exercise Notice.

 

14.  Entire
Agreement. The Plan and Option Agreement are incorporated herein by reference. This Exercise Notice, the Plan, and the Option Agreement
constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings
and agreements of the Company and Optionee with respect to the subject matter hereof, and may not be modified adversely to the Optionee’s
interest except by means of a writing signed by the Company and Optionee.

 

[Signature page follows.]

 

    2020 Stock Option Agreement
Option Number XX-XXXX-X
Page 9 of 10

     

    

 

	Submitted by:	 	 Accepted by:
	 	 	 
	OPTIONEE	 	180 LIFE SCIENCES CORP.
	 	 	 
	  Signature  	 	 	  By:	 
	 	 	 
	Print Name: 	<<Optionee>> 
	 	Print Name: 	 
	 	 	 
	  Address: 	 	 	 	 
	 	 	 
	 	 	  Date Received: 	 

 

 

 

2020 Stock Option Agreement

Option Number XX-XXXX-X

Page 10 of 10Exhibit
4.3

 

180
LIFE SCIENCES CORP.

 

2020
OMNIBUS INCENTIVE PLAN 

 

NOTICE
OF RESTRICTED STOCK GRANT

 

Capitalized
but otherwise undefined terms in this Notice of Restricted Stock Grant and the attached Restricted Stock Grant Agreement shall have the
same defined meanings as in the 180 Life Sciences Corp. 2020 Omnibus Incentive Plan (as amended from time to time) (the “Plan”).

 

Grantee
Name: ________________________________

 

Address:
________________________________

 

You
have been granted Restricted Stock (“Shares”) subject to the terms and conditions of the Plan and the attached
Restricted Stock Grant Agreement, as follows:

 

Date
of Grant: ______________

 

Vesting
Commencement Date: ______________

 

Price
Per Share: ______________

 

Total
Number of Shares Granted: ______________

 

Total
Value of Shares Granted: ______________

 

Total
Purchase Price: $__, Issued In Consideration For Services

 

Agreement
Date: _________________________

 

Vesting
Schedule: ______________________________________.

 

  

    Page 1 of 10
180 Life Sciences Corp.
2020 Omnibus Incentive Plan
Restricted Stock Grant Agreement

     

    

 

180
LIFE SCIENCES CORP.

 

2020
OMNIBUS INCENTIVE PLAN 

 

RESTRICTED
STOCK GRANT AGREEMENT

 

This RESTRICTED
STOCK GRANT AGREEMENT (“Agreement”), dated as of the Agreement Date specified on the Notice of Restricted
Stock Grant is made by and between 180 Life Sciences Corp., a Delaware corporation (the “Company”), and the
grantee named in the Notice of Restricted Stock Grant (the “Grantee,” which term as used herein
shall be deemed to include any successor to Grantee by will or by the laws of descent and distribution, unless the context shall otherwise
require).

 

BACKGROUND

 

Pursuant
to the Plan, the Board (or an authorized Committee thereof), approved the issuance to Grantee, effective as of the date set forth above,
of an award of the number of shares of Restricted Stock as is set forth in the attached Notice of Restricted Stock Grant (which is expressly
incorporated herein and made a part hereof, the “Notice of Restricted Stock Grant”) at the purchase price
per share of Restricted Stock (the “Purchase Price”), if any, set forth in the attached Notice of Restricted
Stock Grant, upon the terms and conditions hereinafter set forth.

 

NOW,
THEREFORE, in consideration of the mutual premises and undertakings hereinafter set forth, the parties agree as follows:

 

1. Grant
and Purchase of Restricted Stock. The Company hereby grants to Grantee, and Grantee hereby accepts the Restricted Stock set forth
in the Notice of Restricted Stock Grant, subject to the payment by Grantee of the total purchase price, if any, set forth in the Notice
of Restricted Stock Grant.

 

2. Stockholder
Rights.

 

(a) Voting
Rights. Until such time as all or any part of the Restricted Stock are forfeited to the Company under this Agreement, if ever, Grantee
(or any successor in interest) has the rights of a stockholder, including voting rights, with respect to the Restricted Stock subject,
however, to the transfer restrictions or any other restrictions set forth in the Plan.

 

(b) Dividends
and Other Distributions. During the period of restriction, Participants holding Restricted Stock are entitled to all regular cash
dividends or other distributions paid with respect to all shares while they are so held. If any such dividends or distributions are paid
in shares, such shares will be subject to the same restrictions on transferability and forfeitability as the Restricted Stock with respect
to which they were paid.

 

    Page 2 of 10
180 Life Sciences Corp.
2020 Omnibus Incentive Plan
Restricted Stock Grant Agreement

     

    

 

3. Vesting
of Restricted Stock.

 

(a) The
Restricted Stock are restricted and subject to forfeiture until vested. The Restricted Stock which have vested and are no longer subject
to forfeiture are referred to as “Vested Shares.” All Restricted Stock which have not become Vested Shares
are referred to as “Nonvested Shares.”

 

(b) Restricted
Stock will vest and become nonforfeitable in accordance with the vesting schedule contained in the Notice of Restricted Stock Grant.

 

(c) Any
Nonvested Shares will automatically vest and become nonforfeitable if Grantee’s service with the Company ceases owing to the Grantee’s
(a) death; or (b) Retirement.

 

(d) Any
Nonvested Shares will vest and become nonforfeitable immediately prior to the date of a Change of Control, provided that the Board (or
an authorized committee thereof), in its discretion, may also accelerate the time at which all or any portion of Grantee’s Nonvested
Shares will vest prior to a contemplated Change of Control.

 

(e) Terms
used in Section 3 and Section 4 have the following meanings:

 

(i) “Cause”
has the meaning ascribed to such term or words of similar import in Grantee’s written employment or service contract with the Company
or its subsidiaries and, in the absence of such agreement or definition, means Grantee’s (i) conviction of, or plea of nolo
contendere to, a felony or crime involving moral turpitude; (ii) fraud on or misappropriation of any funds or property of the
Company or its subsidiaries, or any affiliate, customer or vendor; (iii) personal dishonesty, incompetence, willful misconduct,
willful violation of any law, rule or regulation (other than minor traffic violations or similar offenses), or breach of fiduciary duty
which involves personal profit; (iv) willful misconduct in connection with Grantee’s duties or willful failure to perform
Grantee’s responsibilities in the best interests of the Company or its subsidiaries; (v) illegal use or distribution of drugs;
(vi) violation of any material rule, regulation, procedure or policy of the Company or its subsidiaries, the violation of which
could have a material detriment to the Company; or (vii) material breach of any provision of any employment, non-disclosure, non-competition,
non-solicitation or other similar agreement executed by Grantee for the benefit of the Company or its subsidiaries, all as reasonably
determined by the Board of Directors of the Company, which determination will be conclusive.

 

(ii) “Retirement”
means Grantee’s retirement from Company employ at or above the age 65 as determined in accordance with the policies of the Company
or its subsidiaries, if any, in good faith by the Board of Directors of the Company, which determination will be final and binding on
all parties concerned.

 

    Page 3 of 10
180 Life Sciences Corp.
2020 Omnibus Incentive Plan
Restricted Stock Grant Agreement

     

    

 

(f) Nonvested
Shares may not be sold, transferred, assigned, pledged, or otherwise disposed of, directly or indirectly, whether by operation of law
or otherwise. The restrictions set forth in this Section will terminate upon a Change of Control.

 

4. Forfeiture
of Nonvested Shares. Except as provided herein, if Grantee’s service with the Company ceases for any reason (including
Disability) other than Grantee’s (a) Retirement or (b) death, any Nonvested Shares will be automatically forfeited to the Company
for no consideration; unless the Board (or an authorized committee thereof) provides otherwise, and provided, however, that the Board
(or an authorized committee thereof) may cause any Nonvested Shares immediately to vest and become nonforfeitable if Grantee’s
service with the Company is terminated by the Company without Cause.

 

(a) Legend.
Each certificate representing Restricted Stock granted pursuant to the Notice of Restricted Stock Grant may bear a legend substantially
as follows:

 

“THE
SALE OR OTHER TRANSFER OF THE SHARES REPRESENTED BY THIS CERTIFICATE, WHETHER VOLUNTARY, INVOLUNTARY OR BY OPERATION OF LAW, IS SUBJECT
TO CERTAIN RESTRICTIONS ON TRANSFER AS SET FORTH IN THE 180 LIFE SCIENCES CORP. 2020 OMNIBUS INCENTIVE PLAN AND IN A RESTRICTED SHARE
GRANT AGREEMENT. A COPY OF SUCH PLAN AND SUCH AGREEMENT MAY BE OBTAINED FROM 180 LIFE SCIENCES CORP.”

 

(b) Escrow
of Nonvested Shares. The Company has the right to retain the certificates representing Nonvested Shares in the Company’s possession
until such time as all restrictions applicable to such shares have been satisfied.

 

(c) Removal
of Restrictions. The Participant is entitled to have the legend removed from certificates representing Vested Shares.

 

5. Recapitalizations,
Exchanges, Mergers, Etc. The provisions of this Agreement apply to the full extent set forth herein with respect to any and all
shares of capital stock of the Company or successor of the Company which may be issued in respect of, in exchange for, or in substitution
for the Restricted Stock by reason of any stock dividend, split, reverse split, combination, recapitalization, reclassification, merger,
consolidation or otherwise which does not terminate this Agreement. Except as otherwise provided herein, this Agreement is not intended
to confer upon any other person except the parties hereto any rights or remedies hereunder.

 

    Page 4 of 10
180 Life Sciences Corp.
2020 Omnibus Incentive Plan
Restricted Stock Grant Agreement

     

    

 

6. Grantee
Representations.

 

Grantee
represents to the Company the following:

 

(a) Restrictions
on Transfer. Grantee acknowledges that the Restricted Stock to be issued to Grantee must be held indefinitely unless subsequently
registered and qualified under the Securities Act of 1933, as amended (the “Securities Act”) or unless
an exemption from registration and qualification is otherwise available. In addition, Grantee understands that the certificate representing
the Restricted Stock will be imprinted with a legend which prohibits the transfer of such Restricted Stock unless they are sold in a
transaction in compliance with the Securities Act or are registered and qualified or such registration and qualification are not required
in the opinion of counsel acceptable to the Company.

 

(b) Relationship
to the Company; Experience. Grantee either has a preexisting business or personal relationship with the Company or any of its officers,
directors or controlling persons or, by reason of Grantee’s business or financial experience or the business or financial experience
of Grantee’s personal representative(s), if any, who are unaffiliated with and who are not compensated by the Company or any affiliate
or selling agent, directly or indirectly, has the capacity to protect Grantee’s own interests in connection with Grantee’s
acquisition of the Restricted Stock to be issued to Grantee hereunder. Grantee and/or Grantee’s personal representative(s) have
such knowledge and experience in financial, tax and business matters to enable Grantee and/or them to utilize the information made available
to Grantee and/or them in connection with the acquisition of the Restricted Stock to evaluate the merits and risks of the prospective
investment and to make an informed investment decision with respect thereto.

 

(c) Grantee’s
Liquidity. In reaching the decision to invest in the Restricted Stock, Grantee has carefully evaluated Grantee’s financial
resources and investment position and the risks associated with this investment, and Grantee acknowledges that Grantee is able to bear
the economic risks of the investment. Grantee (i) has adequate means of providing for Grantee’s current needs and possible
personal contingencies, (ii) has no need for liquidity in Grantee’s investment, (iii) is able to bear the substantial
economic risks of an investment in the Restricted Stock for an indefinite period and (iv) at the present time, can afford a complete
loss of such investment. Grantee’s commitment to investments which are not readily marketable is not disproportionate to Grantee’s
net worth and Grantee’s investment in the Restricted Stock will not cause Grantee’s overall commitment to become excessive.

 

(d) Access
to Data. Grantee acknowledges that during the course of this transaction and before deciding to acquire the Restricted Stock, Grantee
has been provided with financial and other written information about the Company. Grantee has been given the opportunity by the Company
to obtain any information and ask questions concerning the Company, the Restricted Stock, and Grantee’s investment that Grantee
felt necessary; and to the extent Grantee availed himself/herself of that opportunity, Grantee has received satisfactory information
and answers concerning the business and financial condition of the Company in response to all inquiries in respect thereof.

 

    Page 5 of 10
180 Life Sciences Corp.
2020 Omnibus Incentive Plan
Restricted Stock Grant Agreement

     

    

 

(e) Risks.
Grantee acknowledges and understands that (i) an investment in the Company constitutes a high risk, (ii) the Restricted Stock
are highly speculative, and (iii) there can be no assurance as to what investment return, if any, there may be. Grantee is aware
that the Company may issue additional securities in the future which could result in the dilution of Grantee’s ownership interest
in the Company.

 

(f) Valid
Agreement. This Agreement when executed and delivered by Grantee will constitute a valid and legally binding obligation of Grantee
which is enforceable in accordance with its terms.

 

(g) Residence.
The address set forth on the Notice of Restricted Stock Grant is Grantee’s current address and accurately sets forth Grantee’s
place of residence.

 

(h) Tax
Consequences. Grantee has reviewed with Grantee’s own tax advisors the federal, state, local and foreign tax consequences of
this investment and the transactions contemplated by this Agreement. Grantee is relying solely on such advisors and not on any statements
or representations of the Company or any of its agents. Grantee understands that Grantee (and not the Company) is responsible for
Grantee’s own tax liability that may arise as a result of the transactions contemplated by this Agreement. Grantee understands
that Section 83 of the Internal Revenue Code of 1986, as amended (the “Code”), taxes as ordinary income
the difference between the purchase price for the Restricted Stock and the fair market value of the Restricted Stock as of the date any
restrictions on the Restricted Stock lapse. Grantee understands that Grantee may elect to be taxed at the time the Restricted Stock is
purchased rather than when and as the restrictions lapse by filing an election under Section 83(b) of the Code with the Internal
Revenue Service within 30 days from the date of purchase. The form for making this election is attached as Exhibit A hereto.

 

GRANTEE
ACKNOWLEDGES THAT IT IS GRANTEE’S SOLE RESPONSIBILITY AND NOT THE COMPANY’S TO FILE TIMELY ANY ELECTION UNDER SECTION 83(b),
EVEN IF GRANTEE REQUESTS THE COMPANY OR ITS REPRESENTATIVES TO MAKE THIS FILING ON GRANTEE’S BEHALF.

 

7. No
Employment Contract Created. The issuance of the Restricted Stock is not to be construed as granting to Grantee any right with
respect to continuance of employment or any service with the Company or any of its subsidiaries. The right of the Company or any of its
subsidiaries to terminate at will Grantee’s employment or terminate Grantee’s service at any time (whether by dismissal,
discharge or otherwise), with or without cause, is specifically reserved, subject to any other written employment or other agreement
to which the Company and Grantee may be a party.

 

    Page 6 of 10
180 Life Sciences Corp.
2020 Omnibus Incentive Plan
Restricted Stock Grant Agreement

     

    

 

8. Tax
Withholding. The Company has the power and the right to deduct or withhold, or require Grantee to remit to the Company, an amount
sufficient to satisfy Federal, state and local taxes (including the Grantee’s FICA obligation) required by law to be withheld
with respect to the grant and vesting of the Restricted Stock.

 

9. Interpretation.
The Restricted Stock are being issued pursuant to the terms of the Plan, and are to be interpreted in accordance therewith. The Board
(or an authorized committee thereof) will interpret and construe this Agreement and the Plan, and any action, decision, interpretation
or determination made in good faith by the Board (or an authorized committee thereof) will be final and binding on the Company and
Grantee.

 

10. Notices.
All notices or other communications which are required or permitted hereunder will be in writing and sufficient if (i) personally
delivered or sent by telecopy, (ii) sent by nationally-recognized overnight courier or (iii) sent by registered or certified
mail, postage prepaid, return receipt requested, addressed as follows:

 

(a) if
to the Grantee, to the address (or telecopy number) set forth on the Notice of Grant; and

 

(b) if
to the Company, to its principal executive office as specified in any report filed by the Company with the Securities and Exchange Commission
or to such address as the Company may have specified to the Grantee in writing, Attention: Corporate Secretary;

 

or
to such other address as the party to whom notice is to be given may have furnished to the other party in writing in accordance herewith.
Any such communication will be deemed to have been given (i) when delivered, if personally delivered, or when telecopied, if telecopied,
(ii) on the first Business Day (as hereinafter defined) after dispatch, if sent by nationally-recognized overnight courier
and (iii) on the fifth Business Day following the date on which the piece of mail containing such communication is posted, if sent
by mail. As used herein, “Business Day” means a day that is not a Saturday, Sunday or a day on which banking
institutions in the city to which the notice or communication is to be sent are not required to be open.

 

11. Specific
Performance. Grantee expressly agrees that the Company will be irreparably damaged if the provisions of this Agreement and the
Plan are not specifically enforced. Upon a breach or threatened breach of the terms, covenants and/or conditions of this Agreement or
the Plan by Grantee, the Company will, in addition to all other remedies, be entitled to a temporary or permanent injunction, without
showing any actual damage, and/or decree for specific performance, in accordance with the provisions hereof and thereof. The Board (or
an authorized committee thereof) has the power to determine what constitutes a breach or threatened breach of this Agreement or
the Plan. Any such determinations will be final and conclusive and binding upon Grantee.

 

    Page 7 of 10
180 Life Sciences Corp.
2020 Omnibus Incentive Plan
Restricted Stock Grant Agreement

     

    

 

12. No
Waiver. No waiver of any breach or condition of this Agreement will be deemed to be a waiver of any other or subsequent breach
or condition, whether of like or different nature.

 

13. Grantee
Undertaking. Grantee hereby agrees to take whatever additional actions and execute whatever additional documents the Company
may in its reasonable judgment deem necessary or advisable in order to carry out or effect one or more of the obligations or restrictions
imposed on Grantee pursuant to the express provisions of this Agreement.

 

14. Modification
of Rights. The rights of Grantee are subject to modification and termination in certain events as provided in this Agreement
and the Plan.

 

15. Governing
Law. This Agreement is governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect
to its conflict or choice of law principles that might otherwise refer construction or interpretation of this Agreement to the substantive
law of another jurisdiction.

 

16. Counterparts;
Facsimile Execution. This Agreement may be executed in one or more counterparts, each of which will be deemed to be an original,
but all of which together will constitute one and the same instrument. Facsimile execution and delivery of this Agreement is legal,
valid and binding execution and delivery for all purposes.

 

17. Entire
Agreement. This Agreement (including the Notice of Restricted Stock Grant) and the Plan, constitute the entire agreement
between the parties with respect to the subject matter hereof, and supersedes all previously written or oral negotiations, commitments,
representations and agreements with respect thereto.

 

18. Severability.
In the event one or more of the provisions of this Agreement should, for any reason, be held to be invalid, illegal or unenforceable
in any respect, such invalidity, illegality or unenforceability will not affect any other provisions of this Agreement, and this Agreement
will be construed as if such invalid, illegal or unenforceable provision had never been contained herein.

 

19. WAIVER
OF JURY TRIAL. THE GRANTEE HEREBY EXPRESSLY, IRREVOCABLY AND UNCONDITIONALLY WAIVES TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING
RELATING TO THIS AGREEMENT AND FOR ANY COUNTERCLAIM THEREIN.

 

[Signature
Page Follows]

 

    Page 8 of 10
180 Life Sciences Corp.
2020 Omnibus Incentive Plan
Restricted Stock Grant Agreement

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Restricted Share Grant Agreement as of the date first written above.

 

180
LIFE SCIENCES CORP.

 

	By:	                                      	 
	 	 	 
	Name: 	 	 
	 	 	 
	Title:	 	 
	 	 	 
	GRANTEE:	 
	 	 	 
	Name:	 	 

 

    Page 9 of 10
180 Life Sciences Corp.
2020 Omnibus Incentive Plan
Restricted Stock Grant Agreement

     

    

 

 

SPOUSE’S
CONSENT TO AGREEMENT

(Required
where Grantee resides in a community property state)

 

I
acknowledge that I have read the Agreement and the Plan and that I know and understand the contents of both. I am aware that my spouse
has agreed therein to the imposition of certain forfeiture provisions and restrictions on transferability with respect to the Restricted
Stock that are the subject of the Agreement, including with respect to my community interest therein, if any, on the occurrence of certain
events described in the Agreement. I hereby consent to and approve of the provisions of the Agreement, and agree that I will abide by
the Agreement and bequeath any interest in the Restricted Stock which represents a community interest of mine to my spouse or to a trust
subject to my spouse’s control or for my spouse’s benefit or the benefit of our children if I predecease my spouse.

 

	Dated:	 	 
	 	 	 
	Signature:	 	 
	 	 	 
	Print Name:	 	 

 

    Page 10 of 10
180 Life Sciences Corp.
2020 Omnibus Incentive Plan
Restricted Stock Grant Agreement

     

    

 

ELECTION
UNDER SECTION 83(b)

OF
THE INTERNAL REVENUE CODE OF 1986

 

The
undersigned taxpayer hereby elects, pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, to include in the
taxpayer’s gross income or alternative minimum taxable income, as the case may be, for the current taxable year, as compensation
for services the excess (if any) of the fair market value of the shares described below over the amount paid for those shares:

 

1. The
name, address, taxpayer identification number and taxable year of the undersigned are as follows:

 

	Taxpayer:	 	 
	Spouse:	 	 
	Name:	 	 
	Address:	 	 
	Identification No.:	 	 
	Taxable Year:	 	 

 

2. The
property with respect to which the election is made is described as follows: __________ shares (the “Shares”) of
the Common Stock of 180 Life Sciences Corp., a Delaware corporation (the “Company”).

 

3. The
date on which the property was transferred is:___________________ ,______.

 

4. The
property is subject to the following restrictions: The Shares may not be transferred and are subject to forfeiture under the terms of
an agreement between the taxpayer and the Company. These restrictions lapse upon the satisfaction of certain conditions contained in
such agreement.

 

5. The
fair market value of the property at the time of transfer (determined without regard to any restriction other than a nonlapse restriction
as defined in § 1.83-3(h) of the Income Tax Regulations) is: $_______ per share x ________ shares = $___________.

 

6. For
the property transferred, the undersigned paid $______ per share x _________ shares = $______________.

 

7. The
amount to include in gross income is $______________. [The result of the amount reported in Item 5 minus the amount reported in
Item 6.]

 

The
undersigned taxpayer will file this election with the Internal Revenue Service office with which taxpayer files his or her annual income
tax return not later than 30 days after the date of transfer of the property. A copy of the election also will be furnished to the person
for whom the services were performed. Additionally, the undersigned will include a copy of the election with his or her income tax return
for the taxable year in which the property is transferred. The undersigned is the person performing the services in connection with which
the property was transferred.

 

The
undersigned understands that the foregoing election may not be revoked except with the consent of the Commissioner.

 

Dated:
______________________, _____

 

___________________________

Taxpayer

 

The
undersigned spouse of taxpayer joins in this election.

 

Dated:
______________________, _____

 

_________________________

Spouse
of Taxpayer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]